UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical devices, sterile packaging, and engineered custom products, has announced its upcoming financial disclosure schedule.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical devices, sterile packaging, and engineered custom products, has announced its upcoming financial disclosure schedule. The company will release its fourth quarter and year-end 2024 financial results on Tuesday, February 25, 2025. This announcement pertains to the financial period ending December 31, 2024.
Details
News Market Reaction – UFPT
The recorded move for UFPT in the trading session of this news was +1.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th.
About UFP Technologies, Inc.
UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Investor Contact:
Jeff Elliott
Three Part Advisors, LLC
214-966-9014
UFP Technologies Contact:
Ron Lataille, CFO
978-234-0926
rlataille@ufpt.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.